-- Curriculum for healthcare providers now offers 13 AAFP Elective credits --
CHARLOTTESVILLE, Va., Oct. 27, 2017 (GLOBE NEWSWIRE) -- TMCIGlobal (TMCI), a leading provider of online medical cannabis education, has received American Academy of Family Physicians (AAFP) CME credit for its, “Clinical Cannabinoid Medicine Curriculum.”
“TMCIGlobal is proud to offer both AAFP and CME credit for this curriculum,” said Vicky Mossman, VP of Partner Development. “Our science-based education offers continuing education to healthcare professionals in all specialties who want to learn more about the clinical application of medical cannabis. With family practitioners being a large part of the learner base for TMCI, we are pleased to see that the American Academy of Family Physicians finds the curriculum acceptable for credit.”
Developed in collaboration with the Society of Cannabis Clinicians (SCC), the Clinical Cannabinoid Medicine Curriculum covers the history of medical cannabis, cannabis ethnobotany, pharmacology and physiologic effects, as well as delivery and dosage. Clinical use for pain, immune disorders, neurodegenerative diseases, mental health conditions and cancer are also presented in this mobile-friendly, comprehensive curriculum.
The Clinical Cannabinoid Medicine Curriculum has been approved for 13 AAFP Elective credits. To learn more about the course, click here. Group pricing is available.
TMCIGlobal (TMCI) provides science-based, online medical education for healthcare professionals who want to learn about medical cannabis and its potential clinical application to deliver quality care and address patient questions. TMCI works with organizations that are recognized as pillars of medical cannabis learning and brings their valuable medical expertise to the healthcare community via an ever-growing online course catalog.
CONTACT: Media Contact: Danielle McNulty | 434-234-0009 | firstname.lastname@example.org